Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 828Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Strattera

PharmaCompass

01

Brand Name : Strattera

Atomoxetine

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Strattera

arrow
Fi Europe 2024
Not Confirmed

Atomoxetine

Main Therapeutic Indication : Neuroscience and Mental Health

Currency : USD

2015 Revenue in Millions : 739

2014 Revenue in Millions : 784

Growth (%) : 6%

blank

02

Brand Name : Strattera

Atomoxetine

arrow
Fi Europe 2024
Not Confirmed

03

Brand Name : Strattera

Atomoxetine

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Strattera

arrow
Fi Europe 2024
Not Confirmed

Atomoxetine

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2016 Revenue in Millions : 855

2015 Revenue in Millions : 784

Growth (%) : 9

blank

04

Brand Name : Strattera

Atomoxetine

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Strattera

arrow
Fi Europe 2024
Not Confirmed

Atomoxetine

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2017 Revenue in Millions : 618

2016 Revenue in Millions : 855

Growth (%) : -28

blank

05

Brand Name : Strattera

Atomoxetine

arrow
Fi Europe 2024
Not Confirmed

Brand Name : Strattera

arrow
Fi Europe 2024
Not Confirmed

Atomoxetine

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 451

2017 Revenue in Millions : 618

Growth (%) : -27%

blank

06

Brand Name : Strattera

Atomoxetine

arrow
Fi Europe 2024
Not Confirmed